MapLight Co-Founder Awarded Nobel Prize for Optogenetics Research
MapLight Therapeutics is celebrating its co-founder, Dr. Karl Deisseroth, for receiving the 2026 Nobel Prize in Physiology or Medicine for his foundational discoveries in optogenetics and circuit mapping. These discoveries have inspired MapLight's approach to drug discovery.